# The optimal single-dose regimen of rasburicase for management of tumour lysis syndrome in children and adults: a systematic review and meta-analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-optimal-single-dose-regimen-of-rasburicase-for-management-of-tumour-lysis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Xiaotong Yu,L. Liu,Xiaolu Nie,Jiapeng Li,Jianchao Zhang,Lu Zhao,Xingkai Wang |
| Citations | 42 |
| DOI | 10.1111/jcpt.12479 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2550381339 |
| PMID | 27888526 |
| Type | review |
| Year | 2016 |

## Paper authors

- [Jiapeng Li](https://scholariq.org/researchers/jiapeng-li/)

## Paper primary topic

- [Methemoglobinemia and Tumor Lysis Syndrome](https://scholariq.org/topics/methemoglobinemia-and-tumor-lysis-syndrome/)

## Paper topics

- [Methemoglobinemia and Tumor Lysis Syndrome](https://scholariq.org/topics/methemoglobinemia-and-tumor-lysis-syndrome/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Gout, Hyperuricemia, Uric Acid](https://scholariq.org/topics/gout-hyperuricemia-uric-acid/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.